Despite the US government’s approval of a stimulus plan and the infusion of additional capital into the financial system, the markets failed to rally in February. The housing market further deteriorated and unemployment claims reached record highs. On February 27, fourth-quarter 2008 US GDP was revised downward to an annualized contraction of 6.2%, the worst […]
Next-generation sequencing is among the fastest-growing markets in the life science instrument market, with 2009 instrument demand estimated to increase more than 40%. The advent of next-generation sequencing has birthed the need for novel approaches to sample preparation (for the purpose of this article, sample preparation encompasses purification, fragmentation, target capture and enrichment prior to […]
Seahorse Bioscience was founded in 2001 with the purpose of developing products to measure drug-induced metabolic changes. The company’s focus shifted, however, when it became clear that there was a need to update the standard technology for cellular bioenergetic measurement in diabetes and obesity research. Clark electrodes, or variations of Clark electrodes, have been used […]
Only half of the 21 companies in the IBO Laboratory Sales Index reported fourth-quarter earnings before the publication of this issue of IBO. For the 11 companies, revenues improved 1.0%, operating profits grew 3.5%, and operating margins improved 60 basis points to 21.9% of sales. Companies, such as Ilumina, Luminex and QIAGEN, sustained strong sales […]
As the US stimulus bill nears passage, the focus on federal government funding of R&D has increased. It is hoped that the stimulus funding will make up some of the declines in US federal R&D funding this fiscal year (see IBO 10/15/08). The drop in federal R&D funding, when adjusted for inflation, over the past […]
Last year was another year of upheaval for R&D operations at the top pharmaceutical companies. Big pharma continued to undergo extensive changes as firms sought to increase the odds of successful drug discovery and development, while reducing R&D costs, in order to maintain profitability as drug patents expire. In addition, new CEOs at Eli Lilly […]
As one of the first instrument shows to test the trade show environment in a new year and an increasingly uncertain economy, LabAutomation2009 showed that optimism about the instrument market remains intact. The annual conference and exhibit that showcases laboratory automation systems and associated products took place January 24–28 in Palm Springs, California. Attendance was […]
Portability has long been touted as a powerful capability of molecular spectroscopy systems, and in the last couple of years portable molecular spectroscopy has gained momentum, especially with the introduction of portable Raman systems. In fact, a number of new products have recently been introduced to the market (see IBO 3/15/08). Among the advantages of […]
The new year began with much of the same disheartening economic news as the previous year’s end, including escalating unemployment rates, subdued retail sales, corporate profit warnings and unrelenting liquidity concerns in the banking sector. For the first two trading weeks of the year, the Dow Jones Industrial Average, S&P 500 and NASDAQ declined 8.3%, […]
Two new websites were recently launched for the lab automation community. The Association for Laboratory Automation‘s LabAutopedia site at www.labautomation.org/labautopedia is a free source of reference information and articles in a “wiki” format, which allows contributions from users. ARTEL launched www.LHTalk.org, a noncommercial site, featuring forums and blogs focused on small-volume liquid handling.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
